SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sensex Topples 400 Points, Nifty Down 0.41% On IT, Pharma Sell-off

Indian equity markets opened weak on Friday amid persistent geopolitical tensions and the ongoing Q4 earnings season. Sensex fell 400 points to 77,263, while Nifty declined 100 points in early trade. IT, financial, and pharma stocks faced heavy selling pressure, with Cipla, Infosys, Dr Reddy’s, Sun Pharma, TCS, and ICICI Bank as top laggards. FMCG and chemical stocks provided some support.

Cipla, Sun Pharma recall drugs in US

… Delhi: Drugmakers Cipla and Sun Pharmaceuticals are undertaking, voluntary recalls of … facility in India. Meanwhile, Sun Pharma is recalling three batches of … . The drug was manufactured by Taro Pharmaceuticals (a wholly owned subsidiary of Sun …

Indian shares fall as crude drifts above $100; financials, autos lead losses

Financials and automakers dragged Indian shares down on Thursday, as Brent crude topped $100 a barrel after Iran seized two ships in the Strait of Hormuz and peace talks showed no sign of resuming. The Nifty 50 lost 0.84% to 24,173.05, while the BSE Sensex shed 1.09% to 77,664. Brent crude rose for a fourth straight session to trade above $103 a barrel as uncertainty over Middle East peace talks lingered. Other Asian markets fell 0.4%. HSBC downgraded Indian equities to “underweight” from “neutral” on Thursday, citing the impact of high energy prices on India. Foreign investors sold a net $4.4 billion worth of Indian shares in April and $18.6 billion so far in 2026. “Despite lingering Mideast tensions, April’s rebound after March’s slump suggests domestic investors are taking comfort in valuations and betting on an early resolution, even as foreign investors stay wary of high oil prices and rupee weakness,” said G. Chokkalingam, founder and head of research at Equinomics Research. Including the session’s losses, the Nifty and Sensex are up about 8% each in April, partially recovering from the more than 11% drop in March.

Alkem Labs CEO Vikas Gupta may exit company

Alkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to depart in the coming months. Gupta joined Alkem from Cipla and has a strong background in the Indian pharmaceutical market.

Brief India: Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums and more

In this briefing: Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) Paracetamol’s Supply Crisis: The Tablet Squeezing Indian Pharma Margins 1. Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Sharda Cropchem is an asset-light agrochemical supplier that sources products mainly from China and India, sells globally, and builds competitive advantage through extensive regulatory product registrations instead of manufacturing capabilities. They invest heavily in product registrations, creating large pipeline that converts into revenue over time, driving strong cash flows funding growth internally, and supporting dividends despite high accounting amortization charges. Sharda’s massive registration pipeline and presence in regulated markets drive growth despite sourcing and forex risks.

Nifty Ends Below 25,800 Amid Profit Booking; Goyal Signals No Rushed Trade Pact

Equity

Cipla Shares Fall To Biggest Intra-day Lows In Six Months Despite Eli Lilly Deal For Diabetes Drug

Nifty Holds Below 26,000; Metals, Realty Shine While FMCG Drags

Sensex, Nifty Poised For A Subdued Opening; HAL, BDL, Mazagon, Cipla, Colgate, Tata Motors, Kaynes Tech Stocks Are In Focus

Diwali 2025 Muhurat Picks: This Brokerage House Picked Nine Stocks With Upto 50% Upside

From Powermech, Gravita India, and Titagarh to J Kumar Infra stocks, ACMIIL’s festive portfolio captures India’s growth engines for 2025. 

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Cipla Ltd.

Neutral Sentiment

<ul class="summary-bullets"><li>Benchmark indices slipped, tracking weak global cues and trade uncertainty.</li><li>Metals bucked the trend, while FMCG and banking counters weighed on indices.</li><li>Global markets turned risk-averse ahead of US inflation data.</li></ul>Indian equity markets ended lower on Friday amid profit booking and uncertainty over progress on the US-India trade deal. Speaking in Berlin, Commerce and Trade Minister Piyush Goyal said that India will not sign any trade deal in a hurry and also made it clear that India will not choose its trade partners at the behest of another country.On Friday, the Sensex closed 344 points lower at 84,211, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended down 96 points at 25,795. Broader markets also ended under pressure, with the Nifty Midcap and Smallcap indices ending 0.1% lower.The retail investor sentiment surrounding the Nifty 50 moved from ‘extremely bearish’ to ‘bearish’ by market close on Stocktwits.<figure class="image"><img style="aspect-ratio:730/91;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_24_153326_png_effbbdf2ff.webp" alt="Screenshot 2025-10-24 153326.png" width="730" height="91"><figcaption>Nifty sentiment and message volume on Oct 24 as of 3:30 pm IST. | source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Stock Moves</h2>Barring metals, real estate, and energy, the rest of the indices ended in the red. Cipla, HUL, and Ultratech Cement were among the top Nifty losers on Friday.Colgate shares ended near their 52-week low after its Q2 earnings missed street estimates. On the other hand, Vakrangee rose 2% and PTC India saw its biggest single-day gain since July 2024 on strong Q2 performance.&nbsp;Kotak Mahindra Bank ended 1% lower ahead of its Q2 earnings print tomorrow.&nbsp;Aluminium stocks such as Hindalco (+4%), NALCO (+3%), and Vedanta (+2%) gained as prices on the London Metals Exchange (LME) climbed past $2,850 per tonne.Utkarsh Small Finance Bank ended 17% higher after the company announced that it has allotted more than 5.71 crore shares to ace investor Madhusudan Kela’s fund house.And Thyrocare ended 2% higher even as its promoter sold a 10% stake.<h2 class="st-heading-2">Markets: What Next?</h2>Globally, European markets traded weak, while US stock futures indicate a subdued start on Wall Street ahead of crucial inflation data.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	13.94	--	--	N/A
Q2 '26	11.55	10.85	-6.09%	MISSED
Q1 '26	10.44	9.76	-6.53%	MISSED
Q4 '25	8.72	6.86	-21.31%	MISSED
Q3 '25	15.01	8.36	-44.31%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

CIPLA.NSE Earnings

Latest Earnings Results: Q2 '26

Historical Earnings